In endometrial cancer, inhibition of both extrinsic (Fas proteins) and intrinsic (Bcl-2 protein family) apoptotic pathways, alterations in PI3K/Akt activity and p53 mutation are known resistance mechanisms. This evidence concerns the gene AKT1 and endometrial cancer.